Has Brittany Morris received payments from drug or device companies?

Yes. Drug and device makers reported $14,392 in general payments to Brittany Morris across 631 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brittany Morris did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brittany Morris come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brittany Morris

Nurse Practitioner · Tampa, FLNPI 1437776242

Payments from drug & device makers

$14,392in general payments, 2019–2025

Across 631 payments — averaging $22.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$2K
Johnson & Johnson$1K
AstraZeneca$737
Incyte Corporation$682
Gilead$672
Daiichi Sankyo Inc.$612
plus $8K from 54 others

What the payments were for

Food & beverage$12,32586%
Education$6054%
Other$1,46310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	72	$2,356
Johnson & Johnson(2 entities)	53	$1,207
AstraZeneca(2 entities)	32	$737
Incyte Corporation	23	$682
Gilead(2 entities)	35	$672
Daiichi Sankyo Inc.	25	$612
Merck	26	$532
Pfizer	24	$447
Sanofi	22	$413
AbbVie	17	$380
E.r. Squibb & Sons, L.L.C.	20	$376
Seagen Inc.	20	$375
Bayer	18	$345
Takeda Pharmaceuticals U.S.A., Inc.	12	$334
Pharmacyclics LLC, An Abbvie Company	8	$331
Lilly USA, LLC	13	$275
Regeneron Healthcare Solutions, Inc.	11	$252
Puma Biotechnology, Inc.	12	$248
Bristol Myers Squibb	12	$231
GSK	11	$225
Amgen	13	$220
Astellas Pharma US Inc	10	$217
Organon	2	$178
Jazz Pharmaceuticals Inc.	9	$168
Genentech USA, Inc.	8	$151
Array Biopharma Inc	8	$145
EMD Serono, Inc.	6	$145
Eisai Inc.	7	$135
Pharmacosmos Therapeutics Inc.	7	$131
Genmab U.S., Inc.	2	$116
Sobi, Inc	6	$111
Tersera Therapeutics LLC	4	$108
Rigel Pharmaceuticals, Inc.	5	$93
Sanofi-aventis U.S. LLC	2	$92
Blueprint Medicines Corporation	6	$83
Pharmaessentia USA Corporation	4	$81
Springworks Therapeutics, Inc.	3	$81
G1 Therapeutics, Inc.	5	$78
Mirati Therapeutics, Inc.	4	$77
Ipsen Biopharmaceuticals, Inc	4	$77
Taiho Oncology, Inc.	4	$62
AVEO Pharmaceuticals, Inc.	3	$55
ADC Therapeutics America, Inc.	3	$52
Deciphera Pharmaceuticals Inc.	3	$50
Legend Biotech USA Inc.	2	$50
Apellis Pharmaceuticals, Inc.	3	$49
Servier Pharmaceuticals LLC	2	$39
Boehringer Ingelheim	2	$38
Dova Pharmaceuticals	2	$38
Epizyme, Inc.	2	$35
Myovant Sciences Inc.	2	$30
Acrotech Biopharma Inc.	2	$30
Kyowa Kirin, Inc.	2	$30
Beone Medicines USA, Inc.	1	$27
Adaptive Biotechnologies Corporation	1	$24
Geron Corporation	1	$22
Foundation Medicine, Inc.	1	$22
Sumitomo Pharma America, Inc.	1	$19
Sun Pharmaceutical Industries Inc.	1	$18
Myriad Genetic Laboratories, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,392 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Exemestane	15	$5,590
Anastrozole	96	$1,422
Tamoxifen Citrate	33	$858
Ondansetron Hcl	11	$739
Raloxifene Hcl	17	$699
Dexamethasone	20	$536
Letrozole	25	$518
Duloxetine Hcl	17	$412
Ondansetron OdtOndansetron	11	$333
Gabapentin	19	$225
Prochlorperazine Maleate	12	$209
Levothyroxine Sodium	13	$190
Potassium Chloride	12	$190
Alendronate Sodium	16	$151
Famotidine	11	$142

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Tampa

April WessonTampa$342K
Lisa NodzonTampa$246K
Ashima BahlTampa$226K
Jennifer PuleoTampa$171K
Melissa CarverTampa$129K
Jerrica FariasTampa$127K
Sara TinsleyTampa$93K
Erin ParkinsonTampa$65K
Michele LaineTampa$58K
Jana BucknerTampa$58K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →